{"id":"W2213105167","doi":"10.1200/jco.2015.33.18_suppl.lba8502","title":"GADOLIN: Primary results from a phase III study of obinutuzumab plus bendamustine compared with bendamustine alone in patients with rituximab-refractory indolent non-Hodgkin lymphoma.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; BC Cancer Agency","funders":"","keywords":"Medicine; Obinutuzumab; Bendamustine; Rituximab; Internal medicine; Clinical endpoint; Refractory (planetary science); Neutropenia; Gastroenterology; Surgery; Lymphoma; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002722472,0.001916381,0.002602753,0.0004554577,0.0003504837,0.00125752,0.0011557,0.001281985,0.003707056],"category_scores_gemma":[0.002011023,0.0007878919,0.002203662,0.0005061829,0.001290797,0.0009455172,0.0005017297,0.003063044,0.0008799378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001151467,"about_ca_system_score_gemma":0.001192252,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001179144,"about_ca_topic_score_gemma":0.002951432,"domain_scores_codex":[0.9990703,0.0005895708,0.00004534717,0.0001033964,0.00005664954,0.0001345894],"domain_scores_gemma":[0.9984925,0.0003652539,0.0003447574,0.00009862479,0.00006226449,0.0006366593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9610425,0.01128331,0.001681088,0.000426154,0.001474952,0.00006675712,0.00009178413,0.0004838276,0.00572104,0.00005607843,0.001157852,0.0165148],"study_design_scores_gemma":[0.8091019,0.1790961,0.007701505,0.00003478125,0.001582295,0.00009050877,0.00003332787,0.0003062579,0.000970375,0.0001159252,0.0009469512,0.00002012178],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876794,0.003853623,0.0006017684,0.0006773986,0.0002129665,0.002625668,0.001956846,0.0001143694,0.00227789],"genre_scores_gemma":[0.9894226,0.001953658,0.001172919,0.00106909,0.0002693687,0.001788032,0.002441446,0.00005382239,0.001829054],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003707056,"threshold_uncertainty_score":0.01439798,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09359959574866157,"score_gpt":0.4035361920180252,"score_spread":0.3099365962693636,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}